Drug Approval

FDA Clinical Trials FDA Regulations Regulatory Processes U.S. Food and Drug Administration Regulatory Review FDA Approval Process Regulatory Affairs USFDA FDA Advisory Committee NHS Alzheimer's Disease Regulatory Agencies Regulations

FDA Approves J&J’s Caplyta for Major Depressive Disorder

The clearance bolsters J&J’s neuroscience strategy following its $14.6 billion Intra‑Cellular Therapies acquisition.